Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 22146-59-4 | MDL No. : | MFCD08275827 |
Formula : | C8H15NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WPPXAQGLXQAVTE-ZCFIWIBFSA-N |
M.W : | 173.21 | Pubchem ID : | 11469346 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.75 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 45.08 |
TPSA : | 66.4 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.72 cm/s |
Log Po/w (iLOGP) : | 1.24 |
Log Po/w (XLOGP3) : | 0.9 |
Log Po/w (WLOGP) : | 0.62 |
Log Po/w (MLOGP) : | 0.53 |
Log Po/w (SILICOS-IT) : | 0.21 |
Consensus Log Po/w : | 0.7 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.85 |
Log S (ESOL) : | -1.22 |
Solubility : | 10.5 mg/ml ; 0.0607 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.88 |
Solubility : | 2.29 mg/ml ; 0.0132 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.9 |
Solubility : | 22.0 mg/ml ; 0.127 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.67 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 143896-77-9 ]
(R)-2-Butyramido-3-methylbutanoic acid
Similarity: 0.93
[ 133849-26-0 ]
(S)-2-Hexanamido-3-methylbutanoic acid
Similarity: 0.91
[ 112243-91-1 ]
(2R,3R)-2-(3-Carboxypropanamido)-3-methylpentanoic acid
Similarity: 0.91
[ 144301-09-7 ]
2-(4-Methylpentanamido)butanoic acid
Similarity: 0.89
[ 55443-74-8 ]
4-Methyl-2-propionamidopentanoic acid
Similarity: 0.89
[ 1307188-77-7 ]
(S)-2-(2-Aminoacetamido)-3,3-dimethylbutanoic acid
Similarity: 0.93
[ 143896-77-9 ]
(R)-2-Butyramido-3-methylbutanoic acid
Similarity: 0.93
[ 133849-26-0 ]
(S)-2-Hexanamido-3-methylbutanoic acid
Similarity: 0.91
[ 112243-91-1 ]
(2R,3R)-2-(3-Carboxypropanamido)-3-methylpentanoic acid
Similarity: 0.91
[ 144301-09-7 ]
2-(4-Methylpentanamido)butanoic acid
Similarity: 0.89